Recent advances in the development of covalent inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recent advances in the development of covalent inhibitors

Published:2021 Issue:7 Volume:12 Page:1037-1045
ISSN:2632-8682
Container-title:RSC Medicinal Chemistry
language:en
Short-container-title:RSC Med. Chem.

Author:

Kim Hyunsoo¹²³⁴⁵,Hwang Yoon Soo¹²³⁴⁵^ORCID,Kim Mingi¹²³⁴⁵,Park Seung Bum¹²³⁴⁵^ORCID

Affiliation:

1. CRI Center for Chemical Proteomics

2. Department of Chemistry

3. Seoul National University

4. Seoul 08826

5. Korea

Abstract

This is the short review focusing on recent advances of covalent warheads that can be applied to the development of potential covalent inhibitors.

Funder

National Research Foundation of Korea

Publisher

Royal Society of Chemistry (RSC)

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biochemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2021/MD/D1MD00068C

Reference44 articles.

1. The resurgence of covalent drugs

2. Covalent inhibitors in drug discovery: from accidental discoveries to avoided liabilities and designed therapies

3. 10 years into the resurgence of covalent drugs

4. Covalent inhibitors: a rational approach to drug discovery

5. Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiscale calculations reveal new insights into the reaction mechanism between KRASG12C and α, β-unsaturated carbonyl of covalent inhibitors;Computational and Structural Biotechnology Journal;2024-12

2. Covalent small-molecule inhibitors of SARS-CoV-2 Mpro: Insights into their design, classification, biological activity, and binding interactions;European Journal of Medicinal Chemistry;2024-11

3. New techniques and strategies in drug discovery (2020–2024 update);Chinese Chemical Letters;2024-09

4. Covalent penicillin-protein conjugates elicit anti-drug antibodies that are clonally and functionally restricted;Nature Communications;2024-08-10

5. Restoring susceptibility to β-lactam antibiotics in methicillin-resistant Staphylococcus aureus;Nature Chemical Biology;2024-07-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3